NORWICH & NORFOLK SURGICAL LTD

Company Registration Number:
10615484 (England and Wales)

Unaudited statutory accounts for the year ended 31 March 2024

Period of accounts

Start date: 1 April 2023

End date: 31 March 2024

NORWICH & NORFOLK SURGICAL LTD

Contents of the Financial Statements

for the Period Ended 31 March 2024

Directors report
Balance sheet
Additional notes
Balance sheet notes

NORWICH & NORFOLK SURGICAL LTD

Directors' report period ended 31 March 2024

The directors present their report with the financial statements of the company for the period ended 31 March 2024

Directors

The directors shown below have held office during the whole of the period from
1 April 2023 to 31 March 2024

Dr T Bosworth
Dr T P Casey
Dr I Churchman
Dr J P Keep
Dr J E Smirl
Dr A Baker
Mr J A Foster
Dr J R Courtenay
Dr M J Korn


The director shown below has held office during the period of
1 April 2023 to 31 December 2023

Mrs M Copson


Secretary Dr J P Keep

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
25 October 2024

And signed on behalf of the board by:
Name: Dr J P Keep
Status: Secretary

NORWICH & NORFOLK SURGICAL LTD

Balance sheet

As at 31 March 2024

Notes 2024 2023


£

£
Fixed assets
Intangible assets: 3 4,474 5,966
Tangible assets: 4 204,895 153,565
Total fixed assets: 209,369 159,531
Current assets
Debtors: 5 218,315 220,200
Cash at bank and in hand: 334,226 189,932
Total current assets: 552,541 410,132
Creditors: amounts falling due within one year: 6 ( 458,332 ) ( 338,523 )
Net current assets (liabilities): 94,209 71,609
Total assets less current liabilities: 303,578 231,140
Total net assets (liabilities): 303,578 231,140
Capital and reserves
Called up share capital: 2 2
Profit and loss account: 303,576 231,138
Total Shareholders' funds: 303,578 231,140

The notes form part of these financial statements

NORWICH & NORFOLK SURGICAL LTD

Balance sheet statements

For the year ending 31 March 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 27 October 2024
and signed on behalf of the board by:

Name: Dr J P Keep
Status: Director

The notes form part of these financial statements

NORWICH & NORFOLK SURGICAL LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Other accounting policies

    Basis of preparation The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss. The financial statements are prepared in sterling, which is the functional currency of the entity.

NORWICH & NORFOLK SURGICAL LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 2. Employees

    2024 2023
    Average number of employees during the period 22 19

NORWICH & NORFOLK SURGICAL LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

3. Intangible assets

Goodwill Other Total
Cost £ £ £
At 1 April 2023 7,458 7,458
Additions
Disposals
Revaluations
Transfers
At 31 March 2024 7,458 7,458
Amortisation
At 1 April 2023 1,492 1,492
Charge for year 1,492 1,492
On disposals
Other adjustments
At 31 March 2024 2,984 2,984
Net book value
At 31 March 2024 4,474 4,474
At 31 March 2023 5,966 5,966

NORWICH & NORFOLK SURGICAL LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

4. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 April 2023 264,242 264,242
Additions 126,368 126,368
Disposals
Revaluations
Transfers
At 31 March 2024 390,610 390,610
Depreciation
At 1 April 2023 110,677 110,677
Charge for year 75,038 75,038
On disposals
Other adjustments
At 31 March 2024 185,715 185,715
Net book value
At 31 March 2024 204,895 204,895
At 31 March 2023 153,565 153,565

NORWICH & NORFOLK SURGICAL LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

5. Debtors

2024 2023
£ £
Trade debtors 201,541 208,643
Other debtors 16,774 11,557
Total 218,315 220,200

NORWICH & NORFOLK SURGICAL LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

6. Creditors: amounts falling due within one year note

2024 2023
£ £
Trade creditors 273,948 258,159
Taxation and social security 4,588 7,375
Other creditors 179,796 72,989
Total 458,332 338,523